AU Stock MarketDetailed Quotes
ATX Amplia Therapeutics Ltd
- 0.067
- -0.001-1.47%
20min DelayMarket Closed Jun 14 15:59 AET
18.20MMarket Cap-2913P/E (Static)
0.070High0.067Low1.41KVolume0.067Open0.068Pre Close95.00Turnover0.09452wk High0.00%Turnover Ratio271.61MShares0.05552wk Low-0.023EPS TTM12.09MFloat Cap167.493Historical HighLossP/E (Static)180.43MShs Float0.041Historical Low-0.023EPS LYR4.41%Amplitude--Dividend TTM1.60P/B1Lot Size--Div YieldTTM
About Amplia Therapeutics Ltd Company
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Company Profile
SymbolATX
Company NameAmplia Therapeutics Ltd
Founded2013
MarketASX
Fiscal Year Ends03-31
Address350 Queen Street Level 17
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 280033650
Websitehttps://www.ampliatx.com
Company Executives
- Name
- Position
- Salary
- Christopher John Burns
- Non Executive Director,Chief Executive Officer,Managing Director
- --
- Warwick Bonner Tong
- Non-Executive Director,Non-Executive Chairman
- --
- Robert Peach
- Non-Executive Director
- --
- Jane Catherine Bell
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg